ABT FY 2018 Earnings Report — Abbott Laboratories Revenue & Financial Results | Market Cap Arena

Abbott LaboratoriesABT

FY 2018 Earnings

Reported February 22, 2019

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2018	Prior Q	FY 2017	QoQ Change	YoY Change
Revenue	$30.6B	—	$27.4B	—	11.6%
Op. Income	$3.8B	—	$2.0B	—	94.9%
Gross Margin	51.7%	—	47.7%	—	4.0pp
Net Margin	7.7%	—	1.7%	—	6.0pp
EPS (Diluted)	$1.34	—	$0.27	—	396.3%
Free Cash Flow	$4.9B	—	$4.4B	—	10.6%

Revenue Flow

Item	Amount
REVENUE	$30.6B
Cost of Revenue	$14.8B
GROSS PROFIT	$15.8B
R&D Expenses	$2.3B
Selling & Marketing	$0
General & Administrative	$9.7B
SG&A Expenses	$9.7B
Other Expenses	$0
Operating Expenses	$12.0B
Cost & Expenses	$26.7B
OPERATING INCOME	$3.8B
Interest Income	$105M
Interest Expense	$729M
Other Income/Expenses	-$971M
INCOME BEFORE TAX	$2.9B
Income Tax Expense	$539M
Net Income from Continuing Ops	$2.3B
Net Income from Discontinued Ops	$34M
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$3.3B
EBIT	$3.6B
EBITDA	$6.9B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$30.6B
Cost of Revenue	$14.8B
GROSS PROFIT	$15.8B
R&D Expenses	$2.3B
Selling & Marketing	$0
General & Administrative	$9.7B
SG&A Expenses	$9.7B
Other Expenses	$0
Operating Expenses	$12.0B
Cost & Expenses	$26.7B
OPERATING INCOME	$3.8B
Interest Income	$105M
Interest Expense	$729M
Other Income/Expenses	-$971M
INCOME BEFORE TAX	$2.9B
Income Tax Expense	$539M
Net Income from Continuing Ops	$2.3B
Net Income from Discontinued Ops	$34M
Other Adjustments	$0
NET INCOME	$2.4B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$2.4B
D&A	$3.3B
EBIT	$3.6B
EBITDA	$6.9B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$2.4B
Depreciation & Amortization	$3.3B
Stock-Based Compensation	$477M
Deferred Income Tax	$293M
Other Non-Cash Items	$32M
Change in Working Capital	-$148M
OPERATING CASH FLOW	$6.3B
Capital Expenditure	-$1.4B
Acquisitions (Net)	$48M
Purchases of Investments	-$131M
Sales/Maturities of Investments	$73M
Other Investing Activities	$48M
NET CASH FROM INVESTING	-$1.4B
Net Debt Issuance	-$8.4B
Common Stock Repurchased	-$238M
Common Dividends Paid	-$2.0B
Other Financing Activities	$271M
NET CASH FROM FINANCING	-$10.4B
FREE CASH FLOW	$4.9B
Net Change in Cash	-$5.6B

Balance Sheet

Item	Amount
Cash & Equivalents	$3.8B
Short-Term Investments	$242M
Net Receivables	$5.2B
Inventory	$3.8B
Other Current Assets	$1.6B
TOTAL CURRENT ASSETS	$14.6B
PP&E (Net)	$7.6B
Goodwill	$23.3B
Intangible Assets	$18.9B
Long-Term Investments	$897M
Tax Assets	$0
Other Non-Current Assets	$1.9B
TOTAL NON-CURRENT ASSETS	$52.5B
TOTAL ASSETS	$67.2B
Account Payables	$3.0B
Short-Term Debt	$207M
Deferred Revenue	$0
Other Current Liabilities	$4.3B
TOTAL CURRENT LIABILITIES	$9.0B
Long-Term Debt	$19.4B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$2.1B
Other Non-Current Liabilities	$6.0B
TOTAL NON-CURRENT LIABILITIES	$27.4B
TOTAL LIABILITIES	$36.5B
Common Stock	$23.5B
Additional Paid-In Capital	$0
Retained Earnings	$24.6B
Treasury Stock	-$10.0B
Accum. Other Comp. Income	-$7.6B
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$30.5B
Minority Interest	$198M
TOTAL EQUITY	$30.7B
TOTAL LIABILITIES & EQUITY	$67.2B
Total Debt	$19.6B
Net Debt	$15.7B